Cargando…
Corrigendum: Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat
Autores principales: | Mao, Yucheng, Ge, Shiyao, Qi, Sufen, Tian, Qing-Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761326/ https://www.ncbi.nlm.nih.gov/pubmed/36545021 http://dx.doi.org/10.3389/fcvm.2022.1094336 |
Ejemplares similares
-
Benefits and risks of antihypertensive medication in adults with different systolic blood pressure: A meta-analysis from the perspective of the number needed to treat
por: Mao, Yucheng, et al.
Publicado: (2022) -
Corrigendum: Racial and Sex Differences in the Response to First-Line Antihypertensive Therapy
por: Clemmer, John S., et al.
Publicado: (2021) -
Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat
por: Wang, Hong-Fei, et al.
Publicado: (2022) -
Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat
por: Geng, Chang, et al.
Publicado: (2023) -
Corrigendum: Systolic blood pressure as the mediator of the effect of early menarche on the risk of coronary artery disease: A Mendelian randomization study
por: Fan, Hsien Yu, et al.
Publicado: (2023)